Dr. Stanley Fahn 23 Jahre Erfahrung

Dr. Stan­ley Fahn, H. Hous­ton Mer­ritt Pro­fes­sor of Neu­ro­lo­gy and Direc­tor of the Cen­ter for Parkinson’s Dise­a­se and Other Move­ment Dis­or­ders at Colum­bia Uni­ver­si­ty in New York City.

Dr. Fahn is the Sci­en­ti­fic Direc­tor of the (Ame­ri­can) Parkinson’s Dise­a­se Foun­da­ti­on and Past Pre­si­dent of the Ame­ri­can Aca­de­my of Neu­ro­lo­gy (AAN). He is foun­der of the Move­ment Dis­or­der Socie­ty and co foun­ded the Par­kin­son Stu­dy Group (PSG), a con­sor­ti­um of cli­ni­cal inves­ti­ga­tors dedi­ca­ted to con­duc­ting con­trol­led cli­ni­cal tri­als on the pre­ven­ti­on and tre­at­ment of PD.

Dr Fahn con­ti­nues to be acti­ve in pati­ent care, rese­arch, and tea­ching and has trai­ned over 120 move­ment dis­or­der fel­lows, inclu­ding many who are pro­fes­sors of neu­ro­lo­gy around the glo­be. Dr. Fahn is the reci­pi­ent of nume­rous hono­urs and awards for out­stan­ding cli­ni­cal rese­arch. Among his many accom­plish­ments are his orga­niz­a­ti­on and exe­cu­ti­on of the deve­lo­p­ment of the Uni­fied Parkinson’s Dise­a­se Rating Sca­le (UPDRS) to deter­mi­ne the seve­ri­ty of Parkinson’s dise­a­se, and the modi­fi­ca­ti­on and popu­la­riz­a­ti­on of the use of the Schwab Eng­land ADL which mea­su­res qua­li­ty of life.

He ser­ved as chair and orga­ni­zer of the first World Par­kin­son Con­gress held in Washing­ton, DC, in 2006, co-orga­ni­zed the second World Par­kin­son Con­gress, held in Glas­gow, Scot­land, in 2010 and co-chai­red the third World Par­kin­son Con­gress in Mont­re­al, Cana­da, in 2013.

His cli­ni­cal rese­arch con­sists of co-aut­ho­ring 135 peer review­ed arti­cles and par­ti­ci­pa­ting in 3 cli­ni­cal tri­als in the past 15 years. In par­ti­cu­lar, he has co-autho­red 107 arti­cles and par­ti­ci­pa­ted in 3 cli­ni­cal tri­als in the stu­dy of Parkinson’s Disease.

Neueste Beiträge

Abstrakte Darstellung einer Zelle.

Stammzellenforschung zu Parkinson

Aktivierung transponierbarer Elemente als Auslöser von Neuroinflammation bei der Parkinson-Krankheit Jüngs­te Stu­di­en auf dem Gebiet der Par­kin­son-Krank­heit haben sich ver­stärkt auf die Rol­le der Neu­ro­in­flamma­ti­on bei der Patho­ge­ne­se der Krank­heit kon­zen­triert. In die­sem Pro­jekt unter­su­chen wir…